Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
By T. Šimůnek, Martin Štìrba, O. Popelová, M. Adamcová, R. Hrdina, V. Geršl. Pharmacological Reports, 2009
762 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/44a2b5f638d8c93b9279ce7a00ee53a6b8f3fe48
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Caroline F. Thorn
- Teri E. Klein
- Russ B. Altman
- Howard L. McLeod
- Tina Hernandez-Boussard
- S. Marsh
- C. Oshiro
- Wen Torng
Citations in the corpus
- Doxorubicin pathways: pharmacodynamics and adverse effects (2011, background): “1 82 58 98 1 [4 2] , 1 97 58 75 9 [1 4]”
- Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation. (2014, neutral): “Despite its highly beneficial effects against cancer, the clinical use of DOX has the serious drawback of cardiotoxicity (2–4).”